See All Slides - tctmd.com

Slides

Presentation TCT 2013

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Presenter: Rudiger Lange

October 29, 2013

Presentation TCT 2013

How Do I Assess an Intermediate Lesion?

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

Three Dimensional Reconstructions of the Left Phrenic Nerve Anatomy in Relation to the Coronary Venous System

Presenter: Julianne Spencer

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

Presenter: David Maron

October 29, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Advertisement

Slides

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

How Do I Assess an Intermediate Lesion?

Three Dimensional Reconstructions of the Left Phrenic Nerve Anatomy in Relation to the Coronary Venous System

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content